Fact Sheet Number 418
- WHAT IS THERAPEUTIC DRUG MONITORING?
- HOW CAN TDM HELP?
- DOES TDM WORK FOR ALL HIV DRUGS?
- DIFFICULTIES WITH TDM
- WHEN CAN TDM HELP?
- FUTURE DIRECTIONS
this Fact Sheet on a single page using: |
|
|
|
More information on Downloading & Printing Fact Sheets |
DRUG MONITORING?
Therapeutic Drug Monitoring, or TDM, means testing a patient’s
blood to check the levels of a medication they are taking. Drug
levels that are too high sometimes cause serious side effects.
Levels that are too low might allow HIV to multiply and develop
resistance.
TDM is not generally used or available yet in the United States.
Researchers do not agree on its benefits.
Even when people take the same dose of a drug, blood levels can
be very different. Several factors can affect drug levels:
- Food effects: more or less drug can be absorbed depending
on how much food is in the stomach, or what kind of food
- Metabolism: how fast the drugs are broken down in the body
- Drug interactions: some drugs affect the metabolism of other
drugs, and can raise or lower their levels.
- Smoking and drinking habits
- Herbal and other supplements. For example, garlic capsules
can reduce blood levels of saquinavir.
- Hepatitis or other liver disease or damage, or kidney problems
- Pregnancy
- Age: children and adolescents process drugs differently than
adults.
If the viral load isn’t going down far enough, it might be
because drug levels are too low. A doctor might be able to increase
the dose and bring HIV under control.
If a patient is having serious side effects, it might be because
drug levels are too high. If they are, a smaller dose might still
control HIV but relieve some side effects.
FOR ALL HIV DRUGS?
TDM might work well for protease inhibitors and for non-nucleoside
reverse transcriptase inhibitors (non-nukes.) Research shows that
blood levels of these types of drugs affect their ability to control
HIV and to cause side effects.
The nucleoside analog reverse transcriptase inhibitors (nukes)
are a different case. They must be processed inside individual
cells before they’re active against HIV. Therefore, the blood
level of these drugs is less important than the amount inside
cells. This is very difficult to measure. We don’t yet know whether
the drug levels of the nukes affect how well they work, or the
side effects they cause. TDM is not yet being used with the nukes.
TDM
1. TDM is not ready for use with the “nuke” drugs.
As noted above, blood levels of the nukes aren’t as important
as the levels inside HIV-infected cells. The technology for measuring
these levels is not very good yet.
2. There isn’t just one target blood level for each drug.
The “best” amount of drug for a patient depends on how
resistant their virus is to that drug. The more resistant the
virus, the higher the blood level of drug needed to control it.
3. It’s difficult to measure drug levels accurately.
With the current technology, repeated tests can give very different
results.
4. Adherence is very important.
Missing doses of a drug can make more of a difference than any
other factor in how well HIV is controlled, and can throw off
the results of TDM.
5. TDM might not make any difference.
Many doctors use a dose of ritonavir to boost blood levels. It
might not be possible to increase the blood levels any further,
even with an increased dose.
6. Lowering blood levels won’t decrease all side effects.
Some side effects aren’t linked to the amount of drug in the body.
Higher doses probably cause more stomach problems with the protease
inhibitors, or kidney stones with indinavir. However, the hypersensitivity
reaction to abacavir is unrelated to the dose of the drug. TDM
won’t reduce this side effect.
7. TDM is expensive.
Because it’s still experimental, it’s difficult to get reimbursement
for TDM.
TDM could provide useful information in several situations:
- For pregnant patients
- For children and teen-aged patients
- To assess interactions between HIV medications
- To assess interactions with non-HIV medications such as birth
control pills, methadone, or TB medications
- For patients with high levels of side effects
- When treatments fail to control HIV even though patients
are taking all their doses
FUTURE
DIRECTIONS
Research will continue on several key questions related to TDM:
1. For each drug, what is the relationship between drug levels
and viral control? How sensitive is it?
2. For each drug side effect, how do drug levels affect the
amount or severity of side effects?
3. How can drug levels of the nukes, inside the cells, be measured
more accurately?
Revised January 19, 2002
to InfoNet Main Page
Index of Fact Sheets
here if you have questions
New Mexico AIDS Education and Training Center
and the New Mexico Department of Health